Literature DB >> 6116661

The mechanism of hepatic coma.

L Zieve.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6116661     DOI: 10.1002/hep.1840010414

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  18 in total

Review 1.  Lactulose, disaccharides and colonic flora. Clinical consequences.

Authors:  M R Clausen; P B Mortensen
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 2.  Adequacy and support of physiological functions in the acutely ill cirrhotic patient.

Authors:  I Giovannini; G Boldrini; C Chiarla; M Castagneto; G Sganga; G Tramutola; F Caracciolo; G Castiglioni
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

3.  Effects of chronic exposure to ammonia on glutamate and glutamine interconversion and compartmentation in homogeneous primary cultures of mouse astrocytes.

Authors:  R Huang; G Kala; R K Murthy; L Hertz
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

Review 4.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

5.  Flow- and pressure-adapted portal arterialization in dogs.

Authors:  H Asakawa; S Kasai; M Mito
Journal:  Jpn J Surg       Date:  1985-07

6.  Raised plasma concentrations of 3-methoxy-4-hydroxyphenylethyleneglycol in cirrhotic patients with or without hepatic encephalopathy.

Authors:  H Echizen; A Minegishi; S Hayashi; N Umeda; T Oda; T Ishizaki
Journal:  Gut       Date:  1989-05       Impact factor: 23.059

7.  Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study.

Authors:  Claudia Sama; Antonio Maria Morselli-Labate; Paolo Pianta; Laura Lambertini; Sonia Berardi; Gabriella Martini
Journal:  Curr Ther Res Clin Exp       Date:  2004-09

8.  Changes in brain ECF amino acids in rats with experimentally induced hyperammonemia.

Authors:  K Suzuki; N Matsuo; T Moriguchi; N Takeyama; Y Kitazawa; T Tanaka
Journal:  Metab Brain Dis       Date:  1992-06       Impact factor: 3.584

9.  Amino acid, ammonia and neurotransmitter concentrations in hepatic encephalopathy: serial analysis in plasma and cerebrospinal fluid during treatment with an adapted amino acid solution.

Authors:  M Rössle; M Luft; R Herz; B Klein; M Lehmann; W Gerok
Journal:  Klin Wochenschr       Date:  1984-09-17

Review 10.  Flumazenil in the treatment of portal systemic encephalopathy--an overview.

Authors:  K Gyr; R Meier
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.